US 8802644
Lipid formulation
granted A61KA61K31/22A61K31/7088
Quick answer
US patent 8802644 (Lipid formulation) held by Tekmira Pharmaceuticals Corporation expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tekmira Pharmaceuticals Corporation
- Grant date
- Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/22, A61K31/7088, A61K31/712, A61K31/713